• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Friday, January 22, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

AFAR Webinar: COVID-19: Can the Science of Aging Move Us Forward?

Bioengineer by Bioengineer
March 18, 2020
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Leading Experts to Discuss How Geroscience Insights and Promising Therapeutics Could Lessen the Severity of Pandemics, Age-Related Diseases

IMAGE

Credit: AFAR


March 18, 2020 (New York, NY) – As the COVID-19 pandemic sweeps the nation and the world, the role that geroscience may play in boosting immunity in older adults and lessening the severity of age-related diseases will be explored by a panel of leading experts in this webinar:

WEBINAR: COVID-19: Can the Science of Aging Move Us Forward?

The no-cost, 90-minute webinar, intended for the scientific community and related science and health media, is scheduled for 1 PM EDT on Tuesday, March 24.

Register now at https://zoom.us/webinar/register/WN_WKctmYzOTV25LYMKvlccLg

Capacity is limited.

Older adults and people with serious medical conditions, such as heart disease, diabetes, and lung disease, are at higher risk of getting very sick from COVID-19. Immune function declines as we age, but research has shown that these aging processes can be targeted. Promising therapeutics called “geroprotectors” hold the potential to boost immunity and lessen the severity of infectious diseases like COVID-19.

Hosted by the American Federation for Aging Research (AFAR), the webinar will:

  • Provide an epidemiological update on COVID-19 in older adults and explain special health care considerations for older people;
  • Connect how the biological processes of aging influence inflammation and immune decline and how the severity of age-related diseases can be diminished through strategies that target the biology of aging; and
  • Present the latest information on promising geroprotectors, including metformin and mTOR inhibitors.

Presenters are:

  • Sean Leng, MD, PhD – Professor of Medicine, Johns Hopkins University School of Medicine, 2006 AFAR Beeson Scholar
  • Nir Barzilai, MD – AFAR Scientific Director; Director, Institute for Aging Research, Albert Einstein College of Medicine
  • George Kuchel, MD, FRCP, AGSF – Director and Chief of Geriatric Medicine, UConn Center on Aging
  • Joan Mannick, MD – Co-Founder and Chief Medical Officer, resTORbio

“At a time when we face a complex public health crisis, it is vitally important to make sure the most up-to-date, reliable scientific information is available to people,” said AFAR Executive Director Stephanie Lederman. “As the leader in advancing research into the biology of aging, AFAR is deeply committed to sharing information not only on what’s happening today, but on what’s next related to the science that can help older adults live healthier and longer.”

###

About AFAR. The American Federation for Aging Research (AFAR) is a national non-profit organization that supports and advances pioneering biomedical research that is revolutionizing how we live healthier and longer. For nearly four decades, AFAR has served as the field’s talent incubator, providing more than $181 million to more than 4,200 investigators at premier research institutions nationwide. A trusted leader and strategist, AFAR also works with public and private funders to steer high quality grant programs and interdisciplinary research networks.

AFAR-funded researchers are finding that modifying basic cellular processes can delay–or even prevent–many chronic diseases, often at the same time. They are discovering that it is never too late–or too early–to improve health. This groundbreaking science is paving the way for innovative new therapies that promise to improve and extend our quality of life–at any age. Learn more at http://www.afar.org or follow AFARorg on Twitter and Facebook.

Media Contact
John Beilenson
[email protected]
610-453-5993

Tags: AgingCell BiologyClinical TrialsGerontologyHealth ProfessionalsImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMortality/LongevityVaccines
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

Potential combined drug therapy for lung cancer

January 22, 2021
IMAGE

University of Cincinnati student uses zebrafish to study spinal deformities

January 22, 2021

Addressing the impact of structural racism on disparities in children with Type 1 diabetes

January 22, 2021

Chimpanzee friends fight together to battle rivals

January 22, 2021
Next Post
IMAGE

Noises from human activity may threaten New England's freshwater soundscape

IMAGE

Late cretaceous dinosaur-dominated ecosystem

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    54 shares
    Share 22 Tweet 14
  • People living with HIV face premature heart disease and barriers to care

    65 shares
    Share 26 Tweet 16
  • New drug form may help treat osteoporosis, calcium-related disorders

    40 shares
    Share 16 Tweet 10
  • New findings help explain how COVID-19 overpowers the immune system

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

cancerInfectious/Emerging DiseasesMaterialsEcology/EnvironmentBiologyGeneticsTechnology/Engineering/Computer ScienceClimate ChangeCell BiologyMedicine/HealthPublic HealthChemistry/Physics/Materials Sciences

Recent Posts

  • SUTD research team extends 4D printing to nanophotonics
  • Potential combined drug therapy for lung cancer
  • 1 million Euros for black holes made from semimetals
  • Highly efficient grid-scale electricity storage at fifth of cost
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In